SY09-4TRANSLATING, HARM REDUCTION INTO POLICIES, THE SWISS EXPERIENCE by Khan, R. et al.
ISAM 2014
16TH INTERNATIONAL SOCIETY OF ADDICTION MEDICINE ANNUALMEETING
2–6 OCTOBER 2014
YOKOHAMA, JAPAN
SY09-4
TRANSLATING, HARMREDUCTION INTO POLICIES, THE SWISS
EXPERIENCE
R. Khan, G. Thorens and D. Zullino
Division of Addictology Department of Mental Health and Psychiatry,
University Hospitals of Geneva, Switzerland
Aims. The aim of this presentation is to illustrate how Switzerland was able to
play such a pioneering role in the field of addiction treatment, by creating a
drug policy integrating the medical prescription of diacetylmorphine (heroin)
in the therapeutic arsenal of addiction treatments.
Discussion. The medical prescription of diacetylmorphine, introduced initially
as a harm reduction measure, has been the exotic element of the Swiss drug
policy of 1991 and probably still is one of the most controversial practices in
clinical medicine despite its documented effectiveness. Coalitions of change
actors, across stakeholder groups from many professions and politicians on
various levels, succeeded in formulating and starting initiatives for a new drug
policy and its innovations.
Conclusion. In the case of Switzerland, the Swiss Confederation took a
leading role by facilitating communication, encouraging scientific knowledge
and bringing the various stakeholders on a platform to deliver a consensual
political policymaking basis. This was facilitated by the Swiss direct democ-
racy system.Sustained, dialogue between researchers and the users, of research
enhances the likelihood of research affecting policy.
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